GOG 0265 Memo: A Phase II Evaluation of ADXS11-001 (IND #13,712) in the Treatment of Persistent or Recurrent Squamous or Non-Squamous Cell Carcinoma of the Cervix

Please visit the GOG legacy website to obtain the information regarding STUDY CLOSURE/SITE MONITORING AND NEW FORMS FOR COMPLETION

View this email in your browser
You are receiving this email because of your relationship with NRG Oncology. Please reconfirm your interest in receiving emails from us. If you do not wish to receive any more emails, you can unsubscribe here.

Four Penn Center 1600 JFK Blvd. Suite1020 , Philadelphia, PA, 19103

Update Profile/Email Address